Stay updated on Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.

Latest updates to the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision updated to v3.3.2, replacing the previous v3.3.1. This is a minor site update with no changes to the study details visible on the page.SummaryDifference0.1%

- Check21 days agoChange DetectedThe Publications section wording was updated to clarify that entries are auto-filled from PubMed and may not be related to the study, and the page revision tag was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page now references the Moffitt Cancer Center Clinical Trials website and sponsor as H. Lee Moffitt Cancer Center and Research Institute, plus a Helpful Links section; a government funding status notice was removed.SummaryDifference0.6%

- Check43 days agoChange DetectedThe new screenshot shows minor layout and styling updates to the Study Details page; core content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

- Check79 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Ibrutinib Combo in CRC Clinical Trial page.